Oncology Plant in Haridwar Successfully Completes USFDA Audit
- Year: 2023
- December 14, 2023
In April 2023, the Oncology Plant located in Haridwar underwent a comprehensive audit by the US Food and Drug Administration (USFDA). This successful audit positions the facility for potential approvals in regulated markets, including the United States and the Middle East. The achievement underscores the company's commitment to maintaining high-quality manufacturing standards and expanding its global footprint in the oncology sector.
Comment
Recent Posts
Shivalik Rasayan API Facility at Dahej (Gujarat) is now USFDA Approved
November 16, 2024
Share This News